Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Modular MedicalMODD +9.11%21 Debt-to-Equity is 0.03 as of Mar. 2026, which is 40% below its 10-year median of 0.05. GuruFocus rates MODD with a GF Score™ of 21/100. The stock has 1 warning sign investors should review. Among 706 Medical Devices & Instruments companies, Modular Medical ranks better than 88.67% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Modular Medical's Debt-to-Equity or its related term are showing as below:
MODD'
s Debt-to-Equity Range Over the Past 10 Years
Min: -2.21 Med: 0.05 Max: 0.3
Current: 0.03
During the past 13 years, the highest Debt-to-Equity Ratio of Modular Medical was 0.30. The lowest was -2.21. And the median was 0.05.
MODD's Debt-to-Equity is ranked better than 88.67% of 706
companies
in the Medical Devices & Instruments industry
Industry Median: 0.225
vs MODD: 0.03
Modular Medical (NAS:MODD) Debt-to-Equity Explanation
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Modular Medical Debt-to-Equity Related Terms
Modular Medical Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Modular Medical's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MODD vs TANAF, CTSO, NMTC: Debt-to-Equity Comparison
For the Medical Devices subindustry, Modular Medical's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Modular Medical Debt-to-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Modular Medical's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Modular Medical's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Modular Medical (MODD) has a Debt-to-Equity of 0.03 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Modular Medical and its competitors. This is 40% below median its historical median of 0.05. According to the industry distribution chart, Modular Medical ranks #80 out of 706 companies in the Medical Devices & Instruments industry, placing it in the top 11.3%.
Is Modular Medical's Debt-to-Equity too high?
Modular Medical's current Debt-to-Equity of 0.03 is 40% below median its 10-year median of 0.05. The Medical Devices & Instruments industry median Debt-to-Equity is 0.23. Modular Medical's value of 0.03 is 86.7% below this industry median. Based on the distribution chart, Modular Medical ranks #80 out of 706 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Modular Medical has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Modular Medical's Debt-to-Equity compare to TANAF and CTSO?
According to the Medical Devices & Instruments industry distribution chart, Modular Medical ranks #80 out of 706 companies for Debt-to-Equity. This places Modular Medical in the top 11% of its industry — outperforming the majority of peers. The industry median Debt-to-Equity is 0.23. Modular Medical's value of 0.03 is 86.7% below this benchmark. While the company's 10-year median is 0.05 vs. the industry median of 0.23, Modular Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.23, based on 706 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Modular Medical's current Debt-to-Equity of 0.03 is 86.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Modular Medical and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Modular Medical's current Debt-to-Equity is 0.03, which is 40% below median its own 10-year median of 0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Modular Medical stock overvalued right now?
Modular Medical (MODD) has a current Debt-to-Equity of 0.03. The current Debt-to-Equity is 0.03, which is 40% below median its 10-year median of 0.05 and 86.7% below the Medical Devices & Instruments industry median of 0.23. Modular Medical's overall GF Score™ is 21/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Modular Medical (MODD), the current Debt-to-Equity is 0.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.
21GF Score
Get the complete analysis for MODD
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MODD has been successfully added to your 
